Plain-English translation of NCT02300766 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a condition called cerebellar mutism syndrome, which can develop in some children after surgery for posterior fossa brain tumors (tumors in the back of the brain). This observational study will collect medical information, imaging scans, speech samples, and blood samples from children across Nordic countries before and after their surgery to understand why this complication happens, who is at risk, and how it progresses over time.
Up to 1 in 4 children who have surgery for posterior fossa brain tumors develop cerebellar mutism syndrome—a condition that causes loss of speech, weakness, poor coordination, and irritability. Doctors don't yet understand what causes this condition, who is most likely to develop it, or how best to treat it. This study aims to find answers by carefully tracking children's symptoms and brain imaging before and after their surgery.
You likely qualify if…
You likely don't qualify if…
You would have medical data collected from your medical records and hospital care at five key time points: before your surgery, and then at several follow-up visits after your surgery. Before and after surgery, doctors will examine your neurological function and speech, and you may be asked to provide recorded speech samples. You'll also have a blood sample taken for genetic analysis. All of this happens as part of your regular cancer care—the study simply gathers and reviews this information through a secure online database shared among participating hospitals in the Nordic countries.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
Austria
Belgium
Czechia
Denmark